Current Management and Future Treatment Strategies for Patients with Metastatic Hormone-Sensitive Prostate Cancer

被引：0
|
作者：
Rajwa, Pawel [1 ,2 ]
Quhal, Fahad [1 ,3 ]
Tsaur, Igor [4 ]
机构：
[1] Med Univ Vienna, Vienna Gen Hosp, Comprehens Canc Ctr, Dept Urol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
[2] Med Univ Silesia, Dept Urol, 3 Maja St 13-15, PL-41800 Zabrze, Poland
[3] King Fahad Specialist Hosp, Dept Urol, Dammam, Saudi Arabia
[4] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept & Outpatient Clin Urol & Pediat Urol, Mainz, Germany
来源：
WORLD JOURNAL OF UROLOGY | 2023年 / 41卷 / 08期
关键词：
D O I：
10.1007/s00345-023-04542-5
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2005 / 2006
页数：2
相关论文
共 50 条
  • [41] Recent developments in the treatment of metastatic hormone-sensitive prostate cancer (mHSPC)
    Schwentner, Christian
    AKTUELLE UROLOGIE, 2022, 53 (01) : 31 - 36
  • [42] Recent progress and controversies in the treatment of metastatic hormone-sensitive prostate cancer
    Liu, Wei-hua
    Yao, Jia-tao
    Ye, Shi-jie
    Hu, Peng-cheng
    Fei, Xin
    Ma, Qi
    Chen, Hai-chao
    JOURNAL OF MENS HEALTH, 2024, 20 (06) : 1 - 7
  • [43] Quality of life considerations in the treatment of metastatic hormone-sensitive prostate cancer
    Chambers, Suzanne K.
    Frydenberg, Mark
    Dunn, Jeff
    LANCET ONCOLOGY, 2019, 20 (11): : 1469 - 1471
  • [44] Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes A Review
    Hussain, Maha
    Fizazi, Karim
    Shore, Neal D.
    Heidegger, Isabel
    Smith, Matthew R.
    Tombal, Bertrand
    Saad, Fred
    JAMA ONCOLOGY, 2024, 10 (06) : 807 - 820
  • [45] Recommendations on the Treatment of Metastatic Hormone-Sensitive Prostate Cancer: Patient Selection
    Borque-Fernando, A.
    Zapatero, A.
    Manneh, R.
    Alonso-Gordoa, T.
    Counago, F.
    Dominguez-Esteban, M.
    Lopez-Valcarcel, M.
    Rodriguez-Antolin, A.
    Sala-Gonzalez, N.
    Sanmamed, N.
    Maroto, P.
    ACTAS UROLOGICAS ESPANOLAS, 2024, 48 (09): : 623 - 631
  • [46] Factors to Guide Treatment Selection for Hormone-Sensitive Metastatic Prostate Cancer
    Tsao, Phoebe A.
    Caram, Megan E. V.
    CANCER JOURNAL, 2020, 26 (01): : 76 - 82
  • [47] The Rapidly Evolving Treatment Landscape of Metastatic Hormone-Sensitive Prostate Cancer
    Yu, Eun-mi
    Patel, Ishan
    Hwang, Min Woo
    Polani, Faran
    Aragon-Ching, Jeanny B.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2024, 18
  • [48] Docetaxel Treatment for Metastatic Hormone-sensitive Prostate Cancer in Daily Practice
    de Groot, Ietsen
    Brinkman, Ithamar
    Luijendijk-de Bruin, Daphne
    Poort, Sharon
    van Rooijen, Johan M.
    EUROPEAN UROLOGY OPEN SCIENCE, 2021, 33 : 48 - 55
  • [49] Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer
    Lee, Ji Hyun
    Jee, Byul A.
    Kim, Jae-Hun
    Bae, Hoyoung
    Chung, Jae Hoon
    Song, Wan
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Park, Se Hoon
    Kang, Minyong
    CANCERS, 2021, 13 (24)
  • [50] Use of abiraterone for patients with metastatic hormone-sensitive prostate cancer (mHSPC)
    Cathomas, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 130 - 130
12345